explore -WSS

explore

author：knowledge 2025-10-02 10:48:57 - browse：16

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Merck, Daiichi strike cancer drug pact worth up to $22 billion

focus

WSS

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Health tech investors get more selective as pandemic boom fades

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Is there really a nursing shortage in the U.S.?

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

UnitedHealth, Optum discontinue NaviHealth name

leisure time

explore

Wikipedia

Heart attack and stroke risk calculators need revising

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Jerome Adams on the need for new antivirals for Covid

STAT Readout: Friday, Oct. 20 biotech updates

Virginia high school admissions case could be legal follow

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Peter Hotez and the public health issue of online harassment

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

After affirmative action ruling, medical educators look to 'holistic review'

The UK government moves asylum

focus

STAT Readout Newsletter: Biotech news today

Biden will tout long

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

Biden will tout long

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

leisure time

entertainment

focus

hotspot